Main Logo
left ventricular remodeling

DocWire News EditorsCardiology | April 6, 2023
The inhibition of SGLT-2 was not associated with an improvement in left ventricular (LV) reverse remodeling in patients ...
Read More
DocWire News EditorsAHA Scientific Sessions 2018 | April 11, 2023
Empagliflozin, an SGLT2 inhibitor, significantly reversed left ventricular (LV) remodeling in a population of diabetic ...